The global robotic catheterization systems market is set to experience significant growth of 14.8% CAGR from 2022 to 2029, with an estimated market value of around USD 42.9 Million as of 2022.
As per Future Market Insights projections, Percutaneous Coronary Intervention applications hold a substantial share of around 73.9% in 2021 in the global robotic catheterization systems market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2021 | USD 36.6 Million |
| Market Value 2029 | USD 112.5 Million |
| CAGR 2022 to 2029 | 14.8% |
| Market Share of Top 5 Countries | 83.1% |
The robotic catheterization systems market is experiencing a development in terms of the digitalization of instruments with it being a chief factor in the advancement of automated and integrated cardiovascular interventional labs. The developments in robotic technology are occurring at a rapid pace, which would assist hospitals in cutting down on catheterization lab costs, chiefly in inaccessible and isolated areas.
The commercialization of such advanced digitalized systems has resulted in the improvement of the operational efficiency of catheterization labs. The factor of high cost is still relevant for such systems, however, the deployment of robotic catheterization systems is gaining pace over the globe owing to their benefits over conventional catheterization procedures.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 15.60% |
| H1, 2022 Projected | 14.78% |
| H1, 2022 Outlook | 14.68% |
| BPS Change - H1, 2022 (O) – H1, 2022 (P) | (-) 10 ↓ |
| BPS Change – H1, 2022 (O) – H1, 2021 | (-) 92 ↓ |
The growth and analysis of the global robotic catheterization systems market were studied by Future Market Insights. The high cost of robotic catheterization procedures and growing awareness concerning complications associated with robotic catheterization systems are responsible for such a drastic drop in BPS in the H1-2022 period.
The comparative analysis performed by Future Market Insights states that the robotic catheterization systems market will witness a downfall of 92 Basis Point Share (BPS) when H1- 2021 and H1- 2022 (O) were compared. BPS change between the projected and outlook period was nearly 10 BPS in H1-2022.
This major downfall was due to factors such as the high cost of robot-assisted catheterization, limited reimbursement, and the COVID-19 impact. Factors such as socio-economic status, low affordability by middle-income group members, and the risks associated with the after-effects of the catheterization process will slow down the growth of the market.
Despite the above mention factors, there are some more points that will contribute to the market growth like, rapid technological advancements which would assist hospitals in cutting down on catheterization lab costs, chiefly in inaccessible and isolated areas and the commercialization of such advanced digitalized systems has resulted in the improvement of the operational efficiency of catheterization labs.
Hence, the deployment of robotic catheterization systems aims to gain pace over the globe owing to their benefits over conventional catheterization procedures in the upcoming years.
The robotic catheterization systems market holds nearly 1% of the overall USD 5.4 Billion Robotic Surgery market in 2021.
Robotic systems for surgical and interventional procedures have now gained a considerable impression on how surgeries are executed and are being gradually implemented in the present operating rooms. Robot-assisted catheterization has demonstrated its ability to perform interventional procedures with vastly low exposure to radiation by the operator as compared to conventional catheterization procedures.
Processes, where clinicians are provided with navigational and mechanical tools which carry out a defined set of actions or a part of a procedure with high precision and control, are now achieved with a robot- catheterization systems. These systems are developed to provide physicians with precision in terms of catheter manipulation and its positioning, while keeping account of its stable control during catheter-associated procedures, vastly for cardiovascular processes.
These systems or medical robots are thus designed to promote physician ability to perform critical medical procedures with precision and control. Moreover, the implementation of robotic catheterization systems also enables the physicians to cause an impact on the target tissue as well as assist with the delivery of medicines or disinfecting agents for infection and disease prevention. Rising advancements in the deployment of robotic catheterization systems in endovascular therapy is an emerging novel approach with significant effects on the reduction in exposure to radiation.
These systems augment the applications of minimally invasive procedures and assist physicians to perform procedures in the domain of neurosurgery, vascular surgery, and interventional cardiology.
The market is expected to expand at a considerable growth rate over the next seven years at a CAGR of close to 14.8%.
Principal Consultant
The opportunistic approach to the robotic catheterization systems market is driven by the factor of reduced risk in terms of occupational hazards with reference to radiation exposure for cardiologists.
During interventional cardiology procedures, it has been reported by the majority of surgeons that the occupational hazards associated with interventional cardiology procedures affected them.
Modern cath labs use ionizing radiation comprehensively in the form of X-rays, which is responsible for the practitioners to be exposure to the risk of malignancy also comprising the neck and head region.
Though preventive measures, such as the utilization of lead aprons may reduce the impact of such risk-associated factors, it is to be noted that their long-term use may be associated with the development of orthopedic injuries among practitioners.
The robotic catheterization systems market is thus set to witness lucrative growth with the advancement in technology as well as the extensive testing of these systems in clinical trials for their efficacy.
Training skilled professionals to perform conventional cardiovascular procedures will further boost the growth of robot-assisted catheterization procedures, such as catheter ablation.
Thus, the reduced impact of risk associated with radiation, the precision of robot-assisted catheterization procedures, and the rising demand for skilled professionals to perform robotic catheterization procedures will drive the growth of the robotic catheterization systems market over the forecast period.
The restricted mechanical capacity of balloon angioplasty in peripheral vascular interventions to recover calcified lesions has given rise to the development of novel technologies using robot-assisted catheterization procedures. Conventionally, a large number of robot-assisted catheterization technologies have been established to assist with the physicians’ ability to operate with percutaneous coronary intervention procedures.
However, their a lack of data comparing the endovascular options, and thus, there is large parity with regard to establishing which robot-assisted catheterization procedure would benefit the patient, depending upon the disease and procedural impact on surgical outcomes. Additionally, the high upfront cost of robotic catheterization systems depicts a negative impact on the end user’s decision to purchase them.
Setting robot-assisted endovascular procedures as the standard of care may take time since special reimbursement for robotic-assisted catheterization is not available.
The lack of studies demonstrating cost-effectiveness and outcome data from manufacturers might make it challenging for care centers to justify investing in the robotic platform. By extending the spectrum of indications for robotic catheterized procedures, manufacturers may improve their applicability and potentially gain market share in the long term.
Other major complications include infection at the insertion site of the robotic catheterization systems guiding wire and catheter, contamination of the burr catheter, and seeding of the catheter.
Growing awareness concerning complications associated with robotic catheterization systems procedures and increasing reluctance concerning the risk of infection, results in low inclination and reluctance towards robotic catheterization system procedures in peripheral vascular intervention by patients.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The USA dominates the North American region with a total market share of around 64.9% in 2021 and is projected to continue experiencing high growth throughout the forecast period.
The growth of this market is driven by the high number of people with disabilities combined with a large geriatric population. Additionally, the growth in the country is also associated with the establishment of key manufacturers and research institutes with dedicated programs relevant to the field of automation and robotics in medicine and healthcare.
United Kingdom is set to exhibit a CAGR of over 14.8% in the European robotic catheterization systems market during the forecast period. The rising burden of disease in the region, along with the wide adoption of clinically approved, mechanical, and automated systems for emergency surgeries has resulted in the lucrative growth that the country of United Kingdom is set to display over the forecast period.
China holds a 40.3% share of the East Asia market in 2021 and is projected to increase at a CAGR rate of 13.3% during the forecast period. The growth of the robotic catheterization systems market in the country is attributed to the rising wave of automation and robotic assistive devices in the region of East Asia, with China as the prime contributor in the development of the industry for robotic devices for various intended uses, including catheterization procedures for patients with specific indications.
In 2021, Japan held a 36.3% share in the East Asia robotic catheterization systems market and is projected to expand at a CAGR of 14.1% from 2022 to 2029. Japan projects significant growth in the global robotic catheterization systems market owing to the recent advancements in the field of interventional procedures being performed by robotic assistance.
In 2018, a novel robot-assisted catheter operating system was studied as a means to decrease physical stress and X-ray exposure time to physicians during endovascular procedures in Japan. The study outcomes led to suggestive procedures with robotic integrated services to it within the country.
Electromechanical Robotic Catheterization Systems project a lucrative growth at a CAGR of 14.8% till the end of the forecast period, with a market share of over 99% in 2021. The growth is associated with the higher efficiency of the electromechanical robotic catheterization systems over the standard magnetic-guided robotic catheterization systems.
Percutaneous Coronary Intervention holds a revenue share of 73.9% in 2021 and is expected to grow with a CAGR of nearly 15.2% during the forecast period. The segment holds the maximum revenue share due to the defined clinical efficacy of robotic catheterization systems in cardiovascular procedures with reduced time and selective area of procedural interventions.
Catheterization Laboratories hold a revenue share of 42.9% in 2021. The development of structured robotic navigations and clinical dexterity of robot-assisted catheterization procedures have improved the time of recovery and high precision of surgical procedures in modern catheterization laboratories. This segment is expected to have a significant growth rate of around 18.3% CAGR during the forecast period.
Strategic collaborations, acquisitions, expansion, product launches, agreements, and research sponsorship are the key strategies adopted by manufacturers to increase product sales in different geographies.
Similarly, recent developments related to companies manufacturing robotic catheterization systems products have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2029 |
| Historical Data Available for | 2014 to 2021 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Germany, United Kingdom, France, Italy, Spain, China, Japan, South Korea, India, Australia, New Zealand, and GCC Countries |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | Siemens; Stereotaxis, Inc; Hansen Medical, Inc. (Johnson & Johnson) |
| Pricing | Available upon Request |
The global robotic catheterization systems market is worth USD 36.6 Million in 2021 and is set to expand 2.6X over the next seven years.
The robotic catheterization systems market is expected to reach USD 112.5 Million by the end of 2029, with sales revenue expected to register 14.8% CAGR.
Portfolio expansion through acquisition and mergers, new product development, and customer-centric approach developments are some of the key trends being witnessed in this marketplace.
The USA, Canada, United Kingdom, Germany, and France are expected to drive demand for robotic catheterization systems products.
North America is one of the key markets for robotic catheterization systems, with the USA expected to account for over 90.4% of the North American market during the forecast period.
Demand for robotic catheterization systems in Europe is expected to register a growth of 14.2% over the next seven years.
The USA, Canada, and Germany are key producers of robotic catheterization systems products.
Siemens, Stereotaxis, Inc, and Hansen Medical, Inc. (Johnson & Johnson) are the key exporters of the robotic catheterization systems market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Market Context 5. Global Market Demand Analysis 2014 to 2021 and Forecast, 2022 to 2029 6. Global Market - Pricing Analysis 7. Global Market Demand (in Value or Size in USD Million) Analysis 2014 to 2021 and Forecast, 2022 to 2029 8. Market Background 9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product Type 9.1. Electromechanical Robotic Catheterization Systems 9.2. Magnetic-Guided Robotic Catheterization Systems 10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Application 10.3.1. Percutaneous Coronary Intervention 10.3.2. Cardiac Electrophysiology Procedures 11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by End User 11.1. Hospitals 11.2. Ambulatory Surgical Centers 11.3. Catheterization Laboratories 12. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region 12.1. North America 12.2. Latin America 12.3. Europe 12.4. East Asia 12.5. South Asia 12.6. Oceania 12.7. Middle East and Africa (MEA) 13. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029 14. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029 15. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029 16. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029 17. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029 18. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029 19. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029 20. Market Structure Analysis 21. Competition Analysis 21.1. Hansen Medical, Inc. (Johnson & Johnson) 21.2. Corindus Vascular Robotics Inc. (Siemens AG) 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Robotic Catheterization Systems Market
